NorthstarVA8 hours agoNVO NUVBU.S. Food and Drug Administration Approves Nuvation Bio’s IBTROZI™ (taletrectinib), a Next-Generation Oral Treatment for Advanced ROS1-Positive Non-Small Cell Lung Cancer
DacubemastrJun 2NVO Took profits on call! I'll look for reentry tmr, possible rejection at 73...I'd like to enter at 70=71
DacubemastrJun 2NVO LET’s GO NVO! Watch the rotation from tech into healthcare and energy guys…we j getting started🙂↔️
DacubemastrMay 28NVO Entered 7/18 75C filled at 2.81, diamond handing till 75...SL will be a 4hr close below the gap